From: Gram-stain-based antimicrobial selection reduces cost and overuse compared with Japanese guidelines
N (%) | |
---|---|
Sputum culture of pulmonary infection | Subtotal = 45 |
Streptococcus pneumoniae | 11 (24.4 %) |
Haemophilus influenzae | 9 (20.0 %) |
Klebsiella pneumoniae | 6 (13.3 %) |
Moraxella catarrhalis | 5 (11.1 %) |
Pseudomonas aeruginosa | 4 (8.8 %) |
Staphylococcus aureus | 4 (8.8 %) |
others | 7 (15.5 %) |
Urine culture of urinary tract infection | Subtotal = 105 |
Escherichia coli | 76 (72.3 %) |
Klebsiella pneumoniae | 9 (8.5 %) |
Citrobacter koseri | 3 (2.8 %) |
Morganella morganii | 3 (2.8 %) |
Enterobacter aerogenes | 2 (1.9 %) |
Enterobacter cloacae | 2 (1.9 %) |
Enterococcus faecalis | 2 (1.9 %) |
Proteus mirabilis | 2 (1.9 %) |
Pseudomonas aeruginosa | 2 (1.9 %) |
Serratia marcescense | 2 (1.9 %) |
Others | 6 (5.7 %) |
Blood culture of skin & soft tissue infection | Subtotal = 58 |
Streptococcus dysgalactiae subsp. equisimilis | 9 (15.5 %) |
Steptococcus agalactiae | 1 (1.7 %) |
negative | 48 (82.7 %) |